- 米国企業
- ProQR Therapeutics N.V.
ProQR Therapeutics N.V.PRQR
時価総額
PER
2017年 12月31日 | 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | |
Property, plant and equipment | 3 | 2 | 2 | 19 | 17 | 16 |
Investments in associates | - | - | - | - | 0 | - |
Non-current financial assets | - | - | - | - | 1 | 1 |
Non-current assets | 3 | 2 | 3 | 19 | 18 | 17 |
Other taxes | 0 | 1 | 1 | 0 | 1 | 1 |
Prepayments and other receivables | 2 | 2 | 2 | 4 | 3 | 59 |
Cash and cash equivalents | 48 | 106 | 112 | 76 | 188 | 95 |
Current assets | 51 | 108 | 115 | 80 | 191 | 154 |
Total assets | 53 | 110 | 118 | 99 | 210 | 171 |
Share capital | 1 | 2 | 2 | 2 | 3 | 3 |
Share premium | 149 | 236 | 287 | 289 | 398 | 413 |
Reserves | - | - | - | - | 30 | 30 |
Retained earnings | -119 | -155 | -212 | -258 | -318 | -381 |
Equity attributable to owners of the Company | 39 | 93 | 94 | 57 | 114 | 65 |
Non-controlling interests | -0 | -0 | -0 | -1 | -1 | -0 |
Total equity | 39 | 93 | 94 | 57 | 113 | 65 |
Borrowings | 5 | 9 | 13 | 16 | 39 | 4 |
Lease liabilities | - | - | - | - | 15 | 14 |
Deferred income | - | - | - | - | 15 | 67 |
Non-current liabilities | 5 | 9 | 13 | 32 | 69 | 85 |
Borrowings | - | - | - | - | - | 3 |
Lease liabilities | - | - | 1 | 1 | 2 | 1 |
Derivative financial instruments | - | - | - | 1 | 4 | 1 |
Trade payables | 1 | 0 | 0 | 0 | 0 | 0 |
Social securities and other taxes | 1 | - | 0 | 0 | 1 | 1 |
Deferred income | - | - | - | - | 5 | 6 |
Other current liabilities | 5 | 7 | 9 | 6 | 11 | 9 |
Current liabilities | 8 | 8 | 11 | 10 | 28 | 21 |
Total liabilities | 14 | 18 | 24 | 42 | 96 | 106 |
Total equity and liabilities | 53 | 110 | 118 | 99 | 210 | 171 |